How Data Impacts GBM/RGB Clinical Trials?
Source: Medidata AI
In this video, Elizabeth Lamont, Senior Medical Director for Medidata AI, describes how an external control arm can be used in rGBM/GBM and the advantages of using a Medidata AI SCA, built upon historical clinical trial data.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Medidata AI
This website uses cookies to ensure you get the best experience on our website. Learn more